Search results
A conversation with Jie He, M.D. & Ph.D., Director, National Cancer Center; President, Cancer Hospital, Chinese Academy of Medical Sciences
He. W. Guo, …, J. He. Neoadjuvant immunotherapy has brought new hope for patients with non-small cell lung cancer (NSCLC). However, limited by the lack of clinically feasible markers, it is still difficult to select NSCLC patients who respond well and to predict patients’ clinical outcomes before the treatment.
Jie He. Objective: To analyze the incidence and mortality rates of esophagus cancer in China from 2008 to 2012. Methods: Incident and mortality cases of esophagus cancer were retrieved from the ...
Aug 24, 2019 · Professor Jie He, CPC member, was born in Aug. 1960 in Changchun City, Jilin Province, having his native place inShenyang, Liaoning. He graduated from Norman Bethune Medical University in 1984 and won Doctor’s Degree from PUMC in 1993. He’s now Head of National Cancer Center, President and Secretary of CPC Committee of CAMS Cancer Hospital ...
Chinese Academy of Medical Sciences Cancer Institute and Hospital: Chaoyang District, Beijing, CN. (Thoracic Surgery) Employment. Show more detail. Source : Jie He.
Aug 1, 2022 · Jie He. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Search for more papers by this author
Aug 24, 2014 · Jie He and colleagues report exome sequencing of 113 tumor-normal pairs of esophageal squamous cell carcinoma. They highlight mutations in genes involved in cell cycle and apoptosis regulation ...
